AbbVie Sees Strong Demand for Its $10 Billion M&A Bond Sale
Investors flocked to drugmaker AbbVie Inc.’s $10 billion investment-grade bond sale after signs of investor fatigue for new debt to fund artificial intelligence efforts.
This is a summary aggregated from Bloomberg Markets. Read the complete article on the original site:
Read full article at Bloomberg Markets